Publications

Al-Harahsheh, M., Rutten, F., Briggs, D., & Kingman, S. Preferential oxidation of chalcopyrite surface facets characterized by ToF-SIMS and SEM. Applied Surface Science 252, 7124. 2006.
Ref Type: Generic

Al-Harahsheh, M., Rutten, F., Briggs, D., & Kingman, S. Oxidation of chalcopyrite surface facets characterized by ToF-SIMS and SEM. International Journal of Mineral Processing 80, 205. 2006.
Ref Type: Generic

Allinson, M., Chapman, S., & Sawyer, J. Creating a novel medicines management support service. Pharmacoepidemiology and Drug Safety [14], S2. 2005.
Ref Type: Abstract

Anderson, A. & Blenkinsopp, A. 2003, "Community pharmacy's contribution to improving public health: learning from local initiatives", Pharmaceutical Journal, vol. 271, pp. 623-625.

Anderson, C., Blenkinsopp, A., & Armstrong, M. 2003, The contribution of community pharmacy to improving the public's health: Evidence from the peer-reviewed literature of 1990-2001, PharmacyHealthLink and Royal Pharmaceutical Society of Great Britain, London, 1.

Anderson, C., Blenkinsopp, A., & Armstrong, M. 2003, "Pharmacists' perceptions regarding their contribution to improving the public's health: a systematic review of the United Kingdom and international literature 1990-2001", IJPP, vol. 11, pp. 111-120.

Anderson, C., Blenkinsopp, A., & Armstrong, M. 2004, "Feedback from community pharmacy users on the contribution of community pharmacy to improving the public's health: a systematic review of the peer reviewed and non-peer reviewed literature 1990-2002", Health Services Journal, vol. 7, pp. 191-202.

Anderson, C. & Blenkinsopp, A. 2006, "Community pharmacy supply of emergency hormonal contraception: a structured literature review of international evidence", Human Reproduction, vol. 21, no. 1, pp. 272-284.

Anjum, K., Staf, K., Mistry, T., Stair, J., & Moss, G. P. "The effect of depilation on the percutaneous absorption of aluminium from antiperspirant products", 12th International perspectives in percutameous penetration.

Archer, J., Blenkinsopp, A., & Black, P. Implementing the Accreditation of Pharmacists with a Special Interest.  1-9-2008. British Pharmaceutical Conference, Manchester.
Ref Type: Art Work

Armstrong, M., Anderson, C., Blenkinsopp, A., & Lewis, S. 2005, "Promoting health through community pharmacies," in Health Promoting Practice, A. Scriven, ed., Palgrave Macmillan.

Ashcroft, D., Quinlan, P., & Blenkinsopp, A. 2005, "Prospective study of the incidence, nature and causes of dispensing errors in community pharmacies", Pharmacoepidemiology and Drug Safety, vol. 14, pp. 327-332.

Aston, J. & Black, P. Does participation in formal postgraduate studies have a positive impact on pharmacists' professional activities. Pharmaceutical Journal 276, 175-179. 2006.
Ref Type: Generic

Aston, J. & Black, P. What barriers might prevent a pharmacist from changing their professional activities following postgraduate study?  2007. British Pharmaceutical Conference, Manchester.
Ref Type: Art Work

Attewell, J., Blenkinsopp, A., & Black, P. 2005, "Community pharmacists and continuing professional development: a qualitative study of perceptions and current involvement", Pharmaceutical Journal, vol. 274, pp. 519-524.

Attewell, J., Blenkinsopp, A., & Black, P. Pharmacy and continuing professional development. Work Based Leaning in Primary Care 4[4], 347-354. 2006.
Ref Type: Generic

Attewell, J., Blenkinsopp, A., & Black, P. Pharmacists and the implementation of continuing professional development: CPD in the real world - some case studies. Work Based Leaning in Primary Care 4, 362-367. 2006.
Ref Type: Generic

Attewell, J., Blenkinsopp, A., & Black, P. Community pharmacists and continuing professional development: a research paper. Work Based Leaning in Primary Care 4[4], 353-361. 2006.
Ref Type: Generic

Attewell, J., Blenkinsopp, A., & Black, P. Introduction: continuing professional development and pharmacists. Work Based Leaning in Primary Care 4, 345-352. 2006.
Ref Type: Generic

Bashford, J. 2003, "A viewpoint from primary care", Midlands Medicine, vol. 23, pp. 26-28.

Beckett, H., Heap, J., McArdle, P., Gilvarry, E., Christian, J., Bloor, R., Crome, I., & Frischer, M. 2003, Precursors and consequences of problematic drug use: A study of young people accessing designated drug services.

Beckett, H., Frisher, M., Heap, J., McArdle, P., & et al 2004, Understanding problem drug use among young people accessing drug services: A multivariate approach using statistical modelling techniques15/04.

Bistrussu, S., Beeton, A., Castaldo, G., Han, J., Wong, I., Tuleu, C., Long, P. F., Brown, K., Cross, N., Cope, J., Goldman, A. P., Karimova, A., O'Callaghan, M., & Robertson, A. 2004, "Are extracorporeal membrane oxygenation (ECMO) circuits stored 'wet-primed' a likely source of infection?", Journal of Clinical Microbiology, vol. 42, no. 8, p. 3906.

Bistrussu, S., Beeton, A., Castaldo, G., Han, J., Wong, I., Tuleu, C., Long, P., Brown, K., Cross, N., Cope, J., Goldman, A., Karimova, A., O'Callaghan, M., Robertson, A., & Smith, L. Are extracorporeal membrane oxygenation (ECMO) circuits stored 'wet-primed' a likely source of infection? Journal of Clinical Microbiology 42[8], 3906. 2004.
Ref Type: Generic

Black, P., Misson, J., & Bracegirdle, L. 2003, "The Formative Developmental Evaluation of an Online Module in Health Promotion using Asynchronous Computer-Mediated Communication", Pharmacy Education, vol. 3, pp. 195-204.

Black, P. & Plowright, D. Learning through reflection: an initial study of pharmacists on a distance learning postgraduate programme. IJPP 13, R24. 2005.
Ref Type: Abstract

Black, P. & Kinsey, J. 2007, "Becoming a Pharmacist Prescriber", Pharmacy Magazine.

Black, P. & Plowright, D. Exploring pharmacists views about the contribution that reflective learning can make to the development of professional practice. International Journal of Pharmacy Practice In press. 2007.
Ref Type: Generic

Black, P. & Taylor, B. 2008, "Pharmacists with special interests", Pharmacy Magazine, vol. 14, no. 5, p. CPD I-VIII.

Black, P. & Plowright, D. 2008, "How postgraduate pharmacy students develop professional understanding: Re-conceptualising deep, reflective learning.", Pharmacy Education, vol. 8, no. 1, pp. 29-35.

Black, P. A model of Reflective Learning for Professional Development.  22-5-2007.
Ref Type: Generic

Blenkinsopp, A., Anderson, A., & Armstrong, M. 2003, "Community pharmacies - underused potential", Prescriberno. 19th October 2003, pp. 10-12.

Blenkinsopp, A., Paxton P, Blenkinsopp, J., & Reid, S. 2003, "Nurse Prescribers: Cold sores", Primary Health Care, vol. 13, no. 6, pp. 35-36.

Blenkinsopp, A. & Bond, C. 2003, "The future healthcare workforce in pharmacy," in The future health workforce, C. Davies, ed., Palgrave Macmillan, Hampshire, pp. 199-221.

Blenkinsopp, A., Reid, S., Blenkinsopp, J., & Paxton, P. 2003, "Prescribing by allied health professionals: The present position", Musculoskeletal Care, vol. 1, no. 1, pp. 72-77.

Blenkinsopp, A. 2003, Minor ailments management and self-care: a scoping study to describe the range of service models.

Blenkinsopp, A., Paxton P, Blenkinsopp, J., & Reid, S. 2003, "Nurse Prescribers: Allergic Conjunctivitis", Primary Health Care, vol. 13, no. 7, pp. 33-34.

Blenkinsopp, A., Jesson, J., Wilson, K., & Langley, C. 2003, What makes an effective PCT pharmacist?  A study of training and development needs.

Blenkinsopp, A., Anderson, C., & Armstrong, M. 2003, The contribution of community pharmacy to improving the public's health: Evidence from the UK non peer-reviewed literature 1990-2001, PharmacyHealthLink and Royal Pharmaceutical Society of Great Britain, London, 2.

Blenkinsopp, A., Paxton, P., Blenkinsopp, J., & Reid, S. 2003, "Nurse Prescribers: Urinary Tract Infection", Primary Health Care, vol. 13, no. 3, pp. 33-34.

Blenkinsopp, A., Paxton P, Blenkinsopp, J., & Reid, S. 2003, "Nurse Prescribers: Otitis Externa", Primary Health Care, vol. 13, no. 9, pp. 33-34.

Blenkinsopp, A. & Black, P. 2003, "The Changing Role of the Pharmacist", Midlands Medicine, vol. 23, pp. 38-41.

Blenkinsopp, A., Paxton P, Blenkinsopp, J., & Reid, S. 2003, "Nurse Prescribers: Allergic Rhinitis", Primary Health Care, vol. 13, no. 4, pp. 33-34.

Blenkinsopp, A., Paxton P, Blenkinsopp, J., & Reid, S. 2003, "Nurse Prescribers: Lower back pain", Primary Health Care, vol. 13, no. 10, pp. 33-34.

Blenkinsopp, A., Paxton P, Blenkinsopp, J., & Reid, S. 2003, "Nurse Prescribers: Mouth Ulcers", Primary Health Care, vol. 13, no. 5, pp. 33-34.

Blenkinsopp, A., Paxton P, Blenkinsopp, J., & Reid, S. 2003, "Nurse Prescribers: Head Lice", Primary Health Care, vol. 13, no. 8, pp. 33-34.

Blenkinsopp, A., Paxton P, Blenkinsopp, J., & Reid, S. 2003, "Nurse Prescribers: Fungal Infections II - Vaginal and oral thrush", Primary Health Care, vol. 13, no. 2, pp. 33-34.

Blenkinsopp, A., Paxton, P., Blenkinsopp, J., & Reid, S. 2003, "Nurse Prescribers: fungal Infections I - Athlete's Foot", Primary Health Care, vol. 13, no. 1, pp. 31-32.

Blenkinsopp, A. & Noyce, P. 2003, Minor illness management in primary care: A review of community pharmacy NHS schemes.

Blenkinsopp, A. 2004, "Ongoing support - the postprescription phase," in Concordance, C. Bond, ed., Pharmaceutical Press, London, pp. 71-90.

Blenkinsopp, A., Paxton, P., & Blenkinsopp, J. 2004, Symptoms in the Pharmacy: A Guide to the Management of Common Illnesses, 5th edn, Blackwell Publishing.

Blenkinsopp, A. & Bond, C. 2004, "Self-care and medication," in Textbook of Primary Medical Care, vol. 1 Jones et al, ed., University Press, Oxford, pp. 111-116.

Blenkinsopp, A., Anderson, C., & Armstrong, M. 2004, "Systematic review of community pharmacy's contribution to reducing risk behaviours in coronary heart disease", Journal of Public Health Medicine, vol. 25, pp. 144-153.

Blenkinsopp, A. & Bond, C. 2005, Over-the-counter medication, BMA publications unit, London, ISBN: 0-9548965-2-1.

Blenkinsopp, A. & Hassey, A. 2005, "Effectiveness and acceptability of community pharmacy-based interventions in type 2 diabetes: a critical review of intervention design, pharmacist and patient perspectives", IJPP, vol. 13, pp. 231-240.

Blenkinsopp, A., Wilkie, P., Wang, M., & Routledge, P. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. British Journal of Clinical Pharmacology (In press). 2006.
Ref Type: Generic

Blenkinsopp, A., Lowe, C., & Black, P. 2008, Prescribing by Foundation Year doctors; Development work in the West Midlands.

Buckley, P., Grime, J., & Blenkinsopp, A. Inter- and intra-professional perspectives on non-medical prescribing in an NHS Trust. Pharmaceutical Journal 277, 394-398. 2006.
Ref Type: Generic

Butler, A. R. & Pearson, R. J. 2005, "Vasodilators for biological research.," in Nitric oxide donors: for pharmaceutical and biological applications., P. G. Wang, ed., Wiley, Weinheim, pp. 203-231.

Celino, G. & Blenkinsopp, A. Local commissioning of community pharmacy services in England prior to the introduction of the new contract. Int J Pharm Pract 14 (Suppl 2), B30. 2006.
Ref Type: Generic

Celino, G. & Blenkinsopp, A. Stakeholder perspectives on barriers to community pharmacy involvement in the care of people with long term conditions. Int J Pharm Pract 14 (Suppl 2), B13. 2006.
Ref Type: Generic

Chambers, R., Wakley, G., & Blenkinsopp, A. Supporting self care in primary care.  2006. Abingdon, Radcliffe Medical Press.
Ref Type: Generic

Chapman, S. & Reeve, E. Risk sharing in a state funded health service: Outcomes Guarantee Project. ?  2003.
Ref Type: Abstract

Chapman, S., Reeve, E., Rajaratnam, G., & Neary, R. 2003, "Setting up an outcomes guarantee for pharmaceuticals: new approach to risk sharing in primary care", BMJ, vol. 326, pp. 707-709.

Chapman, S. 2003, "Puff Adders", Health Services Journal, vol. 113, no. 5883, pp. 6-7.

Chapman, S. & Reeve, E. Sharing the risk of promoting an NSF: the Outcomes Guarantee Project. ?  2003.
Ref Type: Abstract

Chapman, S. & Reeve, E. Outcomes Guarantee - a new initiative to reduce drug wastage in primary care. IJPP [Supplement]. 2003.
Ref Type: Abstract

Chapman, S. 2003, "The Development of Drug Utilisation Research in Europe", European Journal of Pharmaceutical Sciences, vol. 19, pp. 5-14.

Chapman, S. 2003, "Experiences with Professional Education," in Drugs and Money, Seventh edn, M. Dukes et al., eds., IOS Press, Netherlands, pp. 119-125.

Chapman, S. & Reeve, E. Risk sharing in a state funded health service: Outcomes Guarantee Project. ?  2003.
Ref Type: Abstract

Chapman, S. 2004, "ORCA: a new tool for the review of medication in asthma management", Nurse Prescribing, vol. 2, pp. 20-24.

Chapman, S., Durieux, P., & Walley, T. 2004, "Good prescribing practice," in Regulating pharmaceuticals in Europe: striving for efficiency, equity and quality, e. Mossialos, M. Mrazek, & T. Walley, eds., Open University Press, Maidenhead, pp. 144-157.

Chapman, S., Reeve, E., Price, D., Rajaratnam, G., & Neary, R. 2004, "Outcomes guarantee for lipid-lowering drugs: results from a novel approach to risk sharing in primary care", British Journal of Cardiology, vol. 11, pp. 205-10.

Chapman, S. 2004, "Tips for seeing medical representatives.", Supplementary Prescribing in Practice, vol. 1, p. 6.

Chapman, S. Analysis of a new service development: educational out-reach support. Pharmacoepidemiology and Drug Safety [14], S2. 2005.
Ref Type: Abstract

Chapman, S. 5 A.D., "Practitioner, ethical and managerial issues", 260 edn, G. Baker, ed., Royal Society of Medicines Press Ltd, London, pp. 31-34.

Chapman, S. 2007, "Outcome guarantees: putting your money where your mouth is.  (Editorial)", Prescriber, vol. 18, pp. 11-13.

Chapman, S. The Pharmaceutical Price Regulation Scheme. Office of Fair Trading Consultation Panel . 2007.
Ref Type: Generic

Chapman, S. Developing decision support systems for nurse prescribers. Nurse Prescribing 5, 251-255. 2007.
Ref Type: Generic

Chapman, S. Prescribing decision support for diabetes in primary care. Nursing in Practice 36, 15-18. 2007.
Ref Type: Generic

Chapman, S. R. 2007, "Developing a decision support tool for nurse prescribers.", Nursing Times, vol. 103, pp. 29-30.

Chapman, S. R. 2007, "The importance of good prescribing support when determining patients' risk and benefit cannot be underestimated.", Pharmacy in Practice, vol. 17, pp. 219-222.

Chapman, S. R. 2008, "Making decisions about prescribing in diabetes.", Practice Nursing, vol. 19, pp. 128-131.

Chatterton, A., Blenkinsopp, A., & Pollock, K. Support for statin users: A comparison of patient and community pharmacist views on the future. British Pharmaceutical Journal 12[Supplement]. 2004.
Ref Type: Abstract

Chatterton, M., Blenkinsopp, A., & Pollock, K. Patient and community pharmacist perspectives on statins. Int J Pharm Pract 14, 255-262. 2006.
Ref Type: Generic

Claire Jones, Blenkinsopp, A., & G Celino 2005, Implementing a community pharmacy strategy: A practical toolkit for primary care organisations in England, NPC.

Clark, W., Raftery, J., Song, F., Barton, P., Cummins, C., Fry-Smith, A., & Burls, A. 2003, Systematic review and economic evaluation of the effectiveness of Infliximab for the treatment of Crohn's disease7.

Clark, W. & Evans, B. Key therapeutic developments in 2003. Pharmacy Magazine 9[12], CPD1-CPD8. 2003.
Ref Type: Magazine Article

Clyne, W. & Kelham, C. 2006, "A spoonful of sugar: helping patients get more out of medicine", The New Generalist, Journal of the Royal College of General Practitioners., vol. 4, no. 1, pp. 65-66.

Clyne, W., Granby, T., & Picton, C. 2007, A competency framework for shared decision making with patients - achieving concordance for taking medicinesNational Prescribing Centre.

Clyne, W. & Chapman, S. 2008, "Achieving concordance through the use of decision support tools.", Prescriber, vol. 19, no. 8, pp. 41-44.

Clyne, W. & Colin-Thome, D. 2008, "Putting concordance into practice: core consulting skills.", Prescriber, vol. 19, no. 4, pp. 33-36.

Clyne, W., Blenkinsopp, A., & Seal, R. 2008, A guide to medication review.National Prescribing Centre.

Clyne, W., Blenkinsopp, A., & Black, P. Concordant prescribing session in the prescribing module, e-learning for health (e-lfh).  2008.
Ref Type: Internet Communication

Clyne, W. 2007, "Helping practitioners develop consultation skills for talking to patients about medicines", Prescriber, vol. February.

Clyne, W. 2008, "Ambivalence about medicines taking", Prescriber, vol. 19, no. 6, pp. 64-66.

Clyne, W. 2008, "Concordance in community pharmacy", The Pharmacist, vol. Spring Issue, pp. 63-67.

Clyne, W. 2007, "Development of a competency framework for shared decision making", Pharmacy in Practice, vol. 17, no. 7, pp. 253-254.

Connock, M. J., Juarez-Garcia, A., Frew, E., Mans, A., Dretzke, J., Fry-Smith, A., & Moore, D. J. 2006, "A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type 1.", Health Technology Assessment, vol. 10, no. 20, pp. 1-130.

Crome, I. & and Frisher, M. 2008, "Self-harm and substance misuse in the UK - key issues for treatment and research.", Drugs: Education, Prevention and Policy, vol. 15, no. 2, pp. 121-127.

Crome, P. & Pollock, K. 2004, "Age discrimination in prescribing: accounting for concordance", Reviews in Clinical Gerontology, vol. 14, pp. 1-4.

Dennis, A. C., McGarvey, J. J., Woolfson, A. D., McCafferty, D. F., & Moss, G. P. 2004, "A Raman spectroscopic investigation of bioadhesive tetracaine local anaesthetic formulations", International Journal of Pharmaceutics, vol. 279, pp. 43-50.

Dodds, L., Farmer, D., Mackie, C., & Mills, E. 2005, "Defining competency.", Chemist and Druggist, vol. 26, pp. 26-27.

Duerden, M. 2003, "Does clopidogrel reduce ischemic events in the short and long term after acute coronary syndromes?", Evidence-based Cardiovascular Healthcare, vol. 7, pp. 122-123.

Duerden, M., Purves, I., Smart, S., & Finnigan, D. 2003, GDPMRH PRODIGY: Evidence Based Clinical Guidance.

Duerden, M. 2003, "BMJ may have hyped CURE", BMJ, vol. 326, p. 1211.

Duerden, M., Godman, B., Mallinson, M., & Sullivan, N. 2003, "Centralised guidance - how NICE and SIGN impact on care in the UK," in Bausteine fur ein neues Gesundheitswesen, Nomos Verlagsgesellschaft, Baden-Baden, pp. 51-62.

Duerden, M. 2003, "Inhaled corticosteroids are best at lower doses", General Practitionerno. 30th June, pp. 32-33.

Duerden, M., Gogna, N., & Eden, K. 2004, "Current National Initiatives and Policies to Control Drug Costs in Europe: UK Perspective", Journal of Ambulatory Care Management, vol. 27, no. 2, pp. 132-138.

Duerden, M. Guidelines from the British Hypertension Society.  BHS is set to bankrupt NHS. BMJ 329, 569-570. 2004.
Ref Type: Personal Communication

Duerden, M. Do inhaled corticosteroids slow FEV1 decline in COPD after all? Thorax 59, 538-539. 2004.
Ref Type: Personal Communication

Duerden, M. & Phillips, C. 2004, Appraisal of teriparatideJune.

Duerden, M. 2004, "Editorial: New Contract, more Cost-pressure", Prescriber, vol. 15, no. 9, p. 9.

Duerden, M., Allinson, M., & Lockett, J. Timing of simvastatin treatment: No matter the time of day, does UK policy reflect the evidence? BMJ 328, 168. 2004.
Ref Type: Personal Communication

Duerden, M. PROGRESS is about reducing blood pressure, not promoting drugs. BMJ 328, 896. 2004.
Ref Type: Personal Communication

Duerden, M. Prescribing Clopidogrel. Welsh MeReC Bulletin 11[1], 1-4. 2004.
Ref Type: Magazine Article

Evans, B., Clark, W., Moore, D., & Whorwell, P. 2004, "Tegaserod for the treatment of irritable bowel syndrome (Cochrane Review)", The Cochrane Libraryno. 1.

Evans, K. M., Haraldsen, J. D., Pearson, R. J., Slawin, G. E., & Westwood, N. J. 2007, "Synthesis and chemical characterisation of target identification reagents based on an inhibitor of human cell invasion by the parasite Toxoplasma gondii.", Org.Biomol.Chem., vol. 5, pp. 2063-2069.

Fitzpatrick, R., Rajaratnam, G., & Kinsey, J. 2003, "Implementation of NICE Guidance across a health economy.", Journal of Clinical Excellence, vol. 4, no. 3, pp. 318-320.

Fitzpatrick, R. 2003, "Strategic Medicines Management," in Hospital Pharmacy, M. Stephens, ed., Pharmaceutical Press, London.

Fitzpatrick, R. 2003, "Practical Pharmacokinetics," in Clinical Pharmacy and Therapeutics, Third edn, R. Walker & C. Edwards, eds., Churchill Livingstone, London, pp. 20-30.

Fitzpatrick, R. & Boardman, H. A survey of the provision of clinical pharmacy services in relation to existing published standards. Pharmacy World and Science . 2004.
Ref Type: In Press

Fitzpatrick, R. 2004, "Automated Dispensing - developing the business case to support investment", Hospital Pharmacist, vol. 11, no. 3, pp. 109-111.

Fitzpatrick, R. 2004, "Implementing Automation in a Hospital Pharmacy", Hospital Pharmacy Europeno. March/April, pp. 34-37.

Fitzpatrick, R. 2004, "Pharmacy Without Walls", Health Management, vol. 8, no. 7, pp. 22-24.

Fletcher, P., Harman, S., Azijn, H., Armanasco, N., Manlow, P., Perumal, D., de Bethune.M-P., Nuttall.J, Romano, J., & Shattock, R. 2009, "Inhibition of HIV-1 infection by the non-nucleoside reverse transcriptase inhibitor Dapivirine.", Antimicrob Agents Chemother., vol. 53, no. 2, pp. 487-495.

Frischer, M., Crome, I., Croft, P., Millson, D., Collins, J., & Conolly, A. 2003, A national epidemiological study of comorbid substance abuse and psychiatric illness in primary care between 1993-1998 using the GPRDDoH project.

Frischer, M., Heatlie, H., & Hickman, M. 2003, Estimating the prevalence of problematic and injecting drug use for Drug Action Team areas in England: A feasibility study using the Multiple Indicator Method34/04.

Frischer, M., Heatlie, H., & Hickman, M. 2004, Estimated prevalence of problematic and injecting drugs use: Survey of Drug Action Teams in England Home Office Report.

Frischer, M., Collin, M., Millson, D., Crome, I., & Croft, P. 2004, "Prevalence of comorbid psychiatric illness and substance misuse in primary care in England and Wales", Journal of Epidemiological Community Health, vol. 58, no. 12, pp. 1035-1041.

Frischer, M., Crome, I., Green, D., & et al 2005, "Individual and population risk of drug use among adolescents attending an English Youth Offending Team: An epidemiological approach", Journal of Forensic Psychiatry and Psychology, vol. 16, pp. 11-23.

Frischer, M., Heatlie, H., & Hickman, M. Prevalence of problematic and injecting drug use for Drug Action Team areas in England. Journal of Public Health . 2005.
Ref Type: In Press

Frischer, M. & Beckett, H. Drug use desistance. Criminology & Criminal Justice . 2005.
Ref Type: In Press

Frischer, M., Crome, I., Macleod, J., Millson, D., & Croft, P. 2005, "Substance misuse and psychiatric illness: prospective observational study using the general practice research database", Journal of Epidemiology and Community Health, vol. 59, pp. 847-850.

Frischer, M. 2006, "Forecasting drug use", Internation Journal of Drug Policy, vol. 17, pp. 159-163.

Frischer, M. & Heatlie, H. Psychiatric research using General Practice Data. Public Service Review: Health 7, 134-135. 2006.
Ref Type: Generic

Frischer, M. 2006, "Forecasting Drug use: Commentary on "Recent spread of Heroin Use in the United States" by Leon. G Hunt.", International Journal of Drug Policy, vol. 17, no. 3, pp. 159-163.

Frischer, M., Heatlie, H., & Hickman, M. Estimating the prevalence of problematic and injecting drug use for Drug Action Team areas in England. Journal of Public Health 28, 3-9. 2006.
Ref Type: Generic

Frischer, M., Heatlie, H., & and Hickman, M. 2007, "Validating estimates of problematic drug use in England", BMC Public Health   pp. 7-286.

Frisher, M., Collins, C., Millson, D., Crome, I., & Croft, P. 2004, "Prevalence of comorbid psychiatric illness and substance misuse in primary care in England and Wales", Journal of Epidemiological Community Healthno. 58, pp. 1036-1041.

Frisher, M. Drug Use: Commentary on "Recent Spread of Heroin Use in the United States" by Leon G Hunt. International Journal of Drug Policy . 2005.
Ref Type: In Press

Frisher, M. & Martino, O. C. I. C. P. 2009, "Trends in drug misuse recorded in primary care in the UK from 1998 to 2005", J Public Health, vol. 31, no. 1, pp. 69-73.

Frisher, M. & Forsyth, A. 2009, "Assessing the validity of recent estimates of problematic drug use in England.", J Epidemiol Community Health, vol. 63, pp. 87-88.

Frisher, M., Crome, I., Martino, O., & Bashford, J. 2009, "Epidemiology of drug misuse and psychiatric comorbidity in primary care.," in MacGregor S. Responding to Drug misuse. Research and Policy Priorities in Health and Social Care, London & New York, Routlege, Taylor and Francis Group, pp. 151-163.

Frisher, M., Crome, I., & Martino, O. C. P. B. J. 2009, "Epidemiology of Drug misuse and psychiatric comorbidity in Primary care.," in Responding to Drugs Misuse: Research and Policy Priorities in Health and Social Care, 2009 edn, S McGregor Ed.

Frisher, M. & Martino, O. C. I. 2009, "Croft response to Stevens and Reuter Frisher et al.", J Public Health, vol. 31, pp. 309-310.

Gadegaard, N., Chen, X., Rutten, F., & Alexander, M. R. 2008, "High energy electron beam lithography of octadecyl phosphonic acid monolayers on aluminium: grain limit to resolution.", Langmuir, vol. 24, pp. 2057-2063.

Garnier, T. & Moss, G. P. 2009, "Skin case studies," in Clinical case studies in pharmacy, S. Dhillon & R. Raymond, eds., Pharmaceutical Press, London, pp. 294-319.

Gilbert, H., Mills, E., & Ward, E. 2006, "How can community pharmacists become involved in practice research?", Pharmaceutical Journal, vol. 276, p. 104.

Granby T & Chapman, S. 2004, "Evidence-based prescribing," in Independent and Supplementary Prescribing, Courtenay M & Griffiths M, eds., Cambridge University Press, Cambridge, pp. 135-147.

Griffiths, P., Paul, A., Khayat, Z., Duncan, R., Vicent, M., Wan, K.-W., King, S., Grillo, I., Schweins, R., Ferruti, P., & Franchini, J. Understanding the mechanism of action of endosomolytic polymers: correlation of physicochemical and biological properties. Biomacromolecules 5, 1422-1427. 2004.
Ref Type: Generic

Grime, J. & Pollock, K. 2003, "Patients' ambivalence about taking antidepressants: a qualitative study", The Pharmaceutical Journal, vol. 271, pp. 516-519.

Grime, J. & Pollock, K. 2004, "Information versus experience: a comparison of an information leaflet on antidepressants with lay experience of treatment", Patient Education and Counseling, vol. 54, pp. 361-368.

Gullick, D. R., Moss, G. P., Ingram, M. J., Alexander, C., Smart, J. D., & Pugh, W. J. "The in vitrometabolism os captopril carboxy ester prodrugs", 9th International Conference on Perspectives in Percutaneous Penetration, La Grande Motte, France, p. 86.

Gullick, D. R., Moss, G. P., Ingram, M. J., Alexander, C., Smart, J. D., & Pugh, W. J. "The metabolism of captopril carboxyl ester prodrugs: development of in vitro and ex vivomethods", Portsmouth, Uk.

Gullick, D. R., Moss, G. P., Ingram, M. J., Alexander, C., Smart, J. D., & Pugh, W. J. "The in vitropercutaneous absorption of captopril carboxyl ester prodrugs: comparison of fresh vs. frozen skin for a series of carboxyl n-esters", Portsmouth, UK.

Gullick, D. R., Moss, G. P., Ingram, M. J., Alexander, C., Smart, J. D., & Pugh, W. J. "The in vitropecutaneous absorption of captopril carboxyl ester prodrugs", 9th Internationa Conference on Perspectives in Percutaneous Penetration, p. 98.

Gullick, D. R., Cox, P. A., Moss, G. P., & Pugh, W. J. 2005, "In vitro metabolism of captopril ester prodrugs: experimental and novel molecular modelling approaches", J Pharmacy & Pharmacology, vol. 57s, no. (British Pharmaceutical Conference, Manchester), p. 41.

Gullick, D. R., Cox, P. A., Moss, G. P., & Pugh, W. J. 2006, "Captopril prodrugs for transdermal delivery: docking and metabolism with CYP450cl, RNase, and acetylcholinesterase", J Pharmacy & Pharmacology, vol. 58s, no. (British Pharmaceutical Conference, Manchester, UK), p. 17.

Gullick, D. R., Cox, P. A., Ingram, M. J., & Moss, G. P. 2007, "Formulation studies for prodrugs of captopril for enhances percutaneous absorption", J Pharmacy & Pharmacology, vol. 59s, no. (British Pharmaceutical Conference, Manchester), p. 11.

Gullick, D. R., Moss, G. P., Ingram, M. J., Pugh, W. J., & Cox, P. A. "In vitro and in silicoACE-inhibitory activity of metabolically stable captopril ester derivatives for percutaneous absorption", 11th International Conference: Perspectives in Percutaneous Penetration, La Grande Mott, France, p. 56.

Gullick, D. R., Moss, G. P., Cox, P. A., & Pugh, W. J. "A comparison of quantitative models for skin absorption", 9th Annual Meeting of Skin Forum, London, p. 57.

Gullick, D. R., Moss, G. P., Cox, P. A., & Pugh, W. J. "Variation of predicted permiability using calculated and experimental log P values: a comparison of quantitative models for skill absorption", 11th International Perspectives in Percutaneous Penetration, Le Grande Mott, France, p. 57.

Gullick, D. R., Ingram, M. J., Pugh, W. J., Cox, P. A., Gard, P., Smart, J. D., & Moss, G. P. 2009, "Metabolism of captopril carboxy ester derivatives for percutaneous absorption", J Pharmacy & Pharmacology, vol. 61, pp. 159-165.

Gullick, D. R., Moss, G. P., Cox, P. A., Ingram, M. J., & Pugh, W. J. "Characterisation of the drug release of a novel captopril prodrug from a matrix-type patch device", 11th International Perspectives in Percutaneous Penetration, La Grande Mott, France, p. 73.

Gullick, D. R., Pugh, W. J., Ingram, M. J., Cox, P. A., & Moss, G. P. Formulation and characterisation of a captopril ethyl ester drug-in-adhesive type patch for percutaneous absorption. Drug Development and Industrial Pharmacy . 2010.
Ref Type: In Press

Gullick, D. R., Cox, P. A., Pugh, W. J., & Moss, G. P. "Variation of predicted permeability: a comparison of quantitative models for skin absorption", Joint Meeting: 10th Annual Meeting of Skin Forum, and 3rd APSI Skin & Formulation Symposium, Versailles, France, p. 56.

Han, J., Beeton, A., Long, P., Karimova, A., Robertson, A., Cross, N., Smith, L., O'Callaghan, M., Goldman, A., Brown, K., & Tuleu, C. Plasticizer di(2-ethylhexyl)phthalate (DEHP) release in wet-primed extracorporeal membrane oxygenation (ECMO) circuits. International Journal of Pharmaceutics 254[1-2], 157-159. 2004.
Ref Type: Generic

Han, J., Melia, C., & Washington, C. A concentric cylinder shear device for the study of stability in intravenous emulsions. European Journal of Pharmaceutical Sciences 23[3], 253-260. 2004.
Ref Type: Generic

Han, J., Davis, S., Melia, C., & Washington, C. Design and evaluation of an emulsion vehicle for paclitaxel. I. Physicochemical properties. Pharmaceutical Research 22[9], 1573-1580. 2004.
Ref Type: Generic

Han, J., Wong, I., & Tuleu, C. "Extemporaneous tacrolimus suspensions.", 3rd International Workshop on Paediatric Clinical Trials edn.

Han, J. & Tuleu, C. "Stability of a sugar-free sidenafil suspension under simulated user sonditions", Neonatal and Paediatric Pharmacists Group Conference.

Han, J. & Washington, C. Partition of antimicrobial additives in an intravenous emulsion and their effect on emulsion physical stability. International Journal of Pharmaceutics 288[2], 263-271. 2005.
Ref Type: Generic

Han, J., Allison, B., Tuleu, C., Long, P., & Wong, I. Physicochemical and microbiological stability of extemporaneous tacrolimus suspensions. Journal of Clinical Pharmacy and Therapeutics 31, 167-172. 2006.
Ref Type: Generic

Han, J., Davis, S., & Washington, C. Design and evaluation of an emulsion vehicle for paclitaxel.  II: Freeze-drying. Drug Development and Industrial Pharmacy (In Print). 2007.
Ref Type: Generic

Harris, J. D., Roberts, M. L., Perumal, D., Graham, I. R., Patterson, S., & Dickson, G. 2009, "Efficient liver-directed gene transfer by in situ generation of retroviral vector from adenoviral templates.", In Vivo, vol. 23, pp. 885-894.

Hatton, R., Willis, M., Chesters, M., Rutten, F., & Briggs, D. Enhanced hole injection in organic light-emitting diodes using a SAM-derived ultra-thin gold anode supported on ITO glass. J.Mater.Chem 13, 38. 2003.
Ref Type: Generic

Hay, E., Foster, N., Thomas, E., Peat, G., Phelan, P., Yates, H., Blenkinsopp, A., & Sim, J. Effectiveness of community physiotherapy and enhanced pharmacy review for knee pain in people aged over 55 presenting to primary care: pragmatic randomised trial. BMJ 333, 995. 2006.
Ref Type: Generic

Heatlie, H., Chapman, S., Sawyer, J., & Bashford, J. "A comparison between the use of Cox IIs and other NSAIDs using the GPRD", 1 edn, Wiley InterScience, p. S12.

Heatlie, H., Chapman, S., Savage, T., & Bashford, J. A comparison between the use of COX IIs and other NSAIDs using the GPRD. Pharmacoepidemiology and Drug Safety 14[1], S12. 2005.
Ref Type: Generic

Heatlie, H., Chapman, S., Woodvine, P., & Savage, T. Assisting primary care trusts with their analysis of QoF indicators in relation to prescribing. (Abstract). Pharmacoepidemiology and Drug Safety 15, 281-290. 2006.
Ref Type: Generic

Heatlie, H., Woodvine, P., Bashford, J., & Chapman, S. Trends in primary care prescribing for patients with heart failure. (Abstract). Pharmacoepidemiology and Drug Safety 16, 588-595. 2007.
Ref Type: Generic

Hou, Q., Rutten, F., Smith, E., Briggs, D., Davies, M., Buttery, L., Freeman, R., & Shkesheff, K. Surface characterization of preformed alginate fibres incorporated with protein by a novel entrapment process. Surface and Interface Analysis 37, 1077. 2005.
Ref Type: Generic

Hynam, G., Zeller, E., Moss, G. P., & Hall, C. E. 2006, "A potential anti-implantation and spermicidal strategy: Putative derivatives of nonoxynol-9 and anti-inflammatory agents and their spermicidal activity", European Journal of Contraception and Reproductive Healthcare, vol. 11, pp. 258-261.

Ingram, M. J., Edmonds, H., Moss, G. P., Long, A. J., Sosabowski, M. H., & McLennan, M. W. 2004, "The role of handouts in the MPharm degree pathway - differentiation between the inquisitive and acquisitive", Pharmacy Education, vol. 4, pp. 7-12.

Ingram, M. J., Gard, P., Patel, N., Moss, G. P., & Gullick, D. R. 2004, "ACE-inhibitory activity of captopril methyl ester prodrug", J Pharmacy & Pharmacology, vol. 56s, no. (British Pharmaceutical Conference, Manchester), p. 88.

Ingram, M. J., Gard, P., Gale, G., Moss, G. P., & Gullick, D. R. 2005, "Synthesis and in vitrov vascular response of a putative captopril methyl ester nitric oxide releasing prodrug, on aortic helical strips", J Pharmacy & Pharmacology, vol. 57s, no. (British Pharmaceutical Conference, Manchester), p. 79.

Ingram, M. J., Gard, P., Asamoah, N., Moss, G. P., & Gullick, D. R. 2005, "ACE-inhibitory activity of a captopril propyl ester prodrug", J Pharmacy & Pharmacology, vol. 57s, no. (British Pharmaceutical Conference, Manchester), p. 79.

Ingram, M. J., Moss, G. P., & Gullick, D. R. 2006, "Synthesis and ACE-inhibitory activity of a captopril nitroxoxyethylamide a novel hybrid prodrug of captopril and itramine", J Pharmacy & Pharmacology, vol. 58s, no. (British Pharmaceutical Conference, Manchester), p. 85.

Ingram, M. J., Sagoe, L. A., Sosabowski, M. H., Long, A. J., & Moss, G. P. 2007, "Pharmacy student perceptions of educational media tools", Pharmacy Education, vol. 7, pp. 77-82.

Jarvis, C., Beveridge, J., Heard, C. M., McGuigan, C., & Moss, G. P. 2003, "Characteristics of the percutaneous penetration of novel anti-varcella zoster virus nucleoside analogues by confocal laser scanning microscopy", J Pharmacy & Pharmacology, vol. 56S, no. British Pharmaceutical Conference, Harrogate, UK, p. 25.

Jesson, J., Blenkinsopp, A., Wilson, K., & Langley, C. 2004, "Strategic level pharmacists in primary care: activity, training and development needs", Pharmaceutical Journal, vol. 273, pp. 564-569.

Johnson, S., Heard, C. M., & Moss, G. P. "Development of a drug-in-adhesive patch containing extract of Paullinia Cupana", Portsmouth, UK.

Jones, B. & Clark, W. 2003, "Shared care agreements - how to overcome the blank page", Pharmaceutical Journal, vol. 270, pp. 165-166.

Jones, C., Blenkinsopp, A., & Spencer, I. 2003, Implementing a community pharmacy minor ailment scheme: A practical toolkit for primary care organisations and health professionals, NPA, Herts.

Kalaskar, D., Eichhorn, S. J., Gough, J. E., Ulijn, R. V., Sampson, W. W., Alexander, M. R., Rawsterne, R., & Rutten, F. 2008, "Controlling fibroblast morphology by the chemical modification of cellulose fiber scaffolds.", Soft Matter, vol. 4, pp. 1059-1065.

Karimova, A., Robertson, A., Cross, N., Smith, L., O'Callaghan, M., Tuleu, C., Long, P., Beeton, A., Han, J., Ridout, D., Goldman, A., & Brown, K. A wet-primed extracorporeal membrane oxygenation circuit with hollow-fiber membrane oxygenator maintains adequate function for use during cardiopulmonary resusitation after two weeks on standby. Critical Care Medicine 33[7], 1572-1576. 2005.
Ref Type: Generic

Kassianidis, E., Pearson, R. J., & Philp, D. 2005, "Specific autocatalysis in diasteroisomeric replicators.", Org.Lett., vol. 7, pp. 3833-3836.

Kassianidis, E., Pearson, R. J., & Philp, D. 2006, "Probing structural effects on replication efficiency through comparative analyses of families of potential self-replicators.", Chem.Eur.J., vol. 12, no. 34, pp. 8798-8812.

Khan, F., Pearson, R. J., Newton, D. J., Belch, J. J. F., & Butler, A. R. 2003, "Chemical synthesis and microvascular effects of new nitric oxide donors in humans.", Clinical Science, vol. 105, pp. 577-584.

Kraus, L., Augustin, R., Frischer, M., Kummler, P., Uhl, A., & Wiessing, L. 2003, "Estimating prevalence of problem drug use at national level in countries of the European Union and Norway", Addiction, vol. 98, no. 4, pp. 471-485.

Laaksonen, R., Mills, E., Davies, C., Duggan, C., Bates, I., & Mackie, C. 2006, "The self-assessed competence of community pharmacists and participation in clinical training.", Dosis, vol. 22, no. 3, pp. 205-216.

Laaksonen, R., Mills, E., Davies, G., Duggan, C., & Bates, I. 2007, "The effect of training and service provision o the self assessed competence of community pharmacists.", IJPP, vol. 15, pp. 141-147.

Lam, L. T., Bryan, S., Davey, N., Pugh, W. J., Traynor, M. J., Sun, Y., & Moss, G. P. "Machine learning on barrier function of mammalian skin", 11th Gordon Research conference on barrier function of mammalian skin, Waterville Valley, NH.

Lam, L. T., Brown, M. B., Prapodopolou, M., Davey, N., Sun, Y., & Moss, G. P. "On the utility of machine learning methods to quantify percutaneous absorption", Joint Meeting: 10th Annual Meeting of Skin Forum, and 3rd APSI Skin & Formulation Symposium, Versailles, France, p. 57.

Lam, L. T., Brown, M. B., Davey, N., Pugh, W. J., Sun, Y., & Moss, G. P. "The application of machine learning and feature selection methods to the prediction of percutaneous absorption", 12th International perspectives in Percutaneous Penetration.

Lam, L. T., Sun, Y., Davey, N., Adams, R., Prapodopolou, M., Brown, M. B., & Moss, G. P. The application of feature selection to the development of Gaussian Process models for percutaneous absorption. J Pharmacy & Pharmacology . 2010.
Ref Type: In Press

Langley, C., Jesson, J., Wilson, K., & Blenkinsopp, A. 2003, "Postgraduate training offered to primary care pharmacists by schools of pharmacy: changes over the past five years", IJPP, vol. 11, no. Supplement R75.

Long, A. J., Pugh, W. J., Ingram, M. J., Haugh, S., & Moss, G. P. 2008, "The effect of language background on teaching and learning on the M.Pharm", Pharmacy Education, vol. 8, pp. 45-52.

Long, A. J., Pugh, W. J., Ingram, M. J., Haigh, S., & Moss, G. P. 2008, "The effect of language background to teaching and learning on the M.Pharm", Pharmacy Education, vol. 8, pp. 45-52.

Long, P., Han, J., Tuleu, C., & Wong, I. Microbiological Tests on Oral Pediatric Medicines—Requirements for an Improved Pharmacopoeia Monograph. The Annals of Pharmacotherapy 40[1], 158-159. 2006.
Ref Type: Generic

Lutchman, D., Dangor, C. M., & Perumal, D. 2005, "Formulation of rate-modulating pellets for the release of ibuprofen: ann extrusion-spheronization process.", Journal of Microencapsulation, vol. 22, no. 6, pp. 643-659.

Mans, A. 2005, "Key therapeutic developments in 2005.", Pharmacy Magazine, vol. XI, no. 12, pp. 1-8.

Mans, A. 2006, "Key therapeutic developments in 2006.", Pharmacy Magazine, vol. XII, no. 12, pp. 1-8.

McDonald, R., Chapman, S., & Bottomley, J. 2003, "Disease management and the technique of programme budgeting and marginal analysis," in Pharmacoeconomics, T. Walley, A. Haycox, & A. Boland, eds., Churchill Livingstone, London, pp. 71-83.

McDonald, R., Chapman, S., & Bottomley, J. 2004, "Disease management and the technique of programme budgeting and marginal analysis," in Pharmacoeconomics, T. Walley et al., eds., Churchill Livingstone, pp. 71-83.

Mills, E., Blenkinsopp, A., & Black, P. Prescribing in Foundation Year One: A comprehendium of training, assessment and clinical governance resources. West Midlands Workforce Deanery: Dept.of Medicines Management . 2008.
Ref Type: Generic

Mills, E., Black, P., & Blenkinsopp, A. 2008, Future quality management strategies for pharmacy pre-registration training.

Mills, E., Black, P., & Blenkinsopp, A. Future quality management strategies for pharmacy Pre-registration training: A scoping study. West Midlands Workforce Deanery: Dept.of Medicines Management . 2009.
Ref Type: Generic

Mills, E., Farmer, D., Bates, I., Davies, G., Webb, D., & McRobbie, D. 2005, "The development of an evidence-led competency framework for pharmacists working in primary care and the community.", Pharmaceutical Journal, vol. 275, pp. 48-52.

Mills, E., Farmer, D., Bates, I., Davies, G., & Webb, D. 2008, "The General Level Framework: use in primary care and community pharmacy to support professional development.", IJPP, vol. 16, pp. 325-331.

Mills, E. & Black, P. 2009, "Self-directed learning and advanced practice development in pharmacy.", Pharmaceutical Journal, vol. 283, p. 535.

Mills, E., Laaksonen, R., Bates, I., Davies, G., & Duggan, C. 2010, "Self-assessment of competence in a community pharmacy setting.", Pharmacy in Practice, vol. 5, no. 3, pp. 189-199.

Moss, G. P., Gullick, D. R., Ingram, M. J., Alexander, C., Smart, J. D., & Pugh, W. J. 2003, "Synthesis and Characterisation of captopril carboxylate-ester prodrugs", J Pharmacy & Pharmacology, vol. 56S, no. British Pharmaceutical Conference, Harrogate, UK, p. 42.

Moss, G. P., Dennis, A. C., McGarvey, J. J., Woolfson, A. D., & McCafferty, D. F. 2003, "Surface-enhanced Raman spectroscopy if tetracaine deposition in the stratum corneum", J Pharmacy & Pharmacology, vol. 56S, no. British Pharmaceutical Conference, p. 29.

Moss, G. P., Gullick, D. R., Ingram, M. J., Gard, P., & Patel, N. "ACE-inhibitory activity of captopril methyl ester prodrug", Portsmouth, UK.

Moss, G. P. 2004, "Prodrugs for enhanced percutaneous absorption", J Pharmacy & Pharmacology, vol. 56s, no. (British Pharmaceutical Conference, Manchester), p. 100.

Moss, G. P., Dibben, S. D., Gullick, D. R., Thomas, S. K., & Pugh, W. J. 2004, "The in vitro percutaneous absorption of aluminium from topical products", J Pharmacy & Pharmacology, vol. 56s, no. (British Pharmaceutical Conference, Manchester), p. 68.

Moss, G. P., Dibben, S. D., Gullick, D. R., Thomas, C. P., & Pugh, W. J. "The in vitro percutaneous absorption of aluminium from topical products", Portsmouth, UK.

Moss, G. P., Gullick, D. R., & Pugh, W. J. 2005, "Multiple-application dosing: effect on the percutaneous absorption of aluminium from commercially available products", J Pharmacy & Pharmacology, vol. 57s, p. 104.

Moss, G. P., Gullick, D. R., & Pugh, W. J. 2005, "Do QSPR models accurately reflect percutraneous absorption?", J Pharmacy & Pharmacology, vol. 57s, no. (British Pharmaceutical Conference, Manchester), p. 18.

Moss, G. P., Woolfson, A. D., Gullick, D. R., & McCafferty, D. F. 2006, "Mechanical characterisation and drug permeation properties of tetracaine-loaded bioadhesive films for percutaneous local anaesthesia", Drug Development and Industrial Pharmacy, vol. 32, pp. 163-174.

Moss, G. P., Gullick, D. R., Cox, P. A., & Pugh, W. J. 2006, "A comparison of predicted and experimentally measured descriptors in QSPRs", J Pharmacy & Pharmacology, vol. 58s, no. (British Pharmaceutical Conference, Manchester), p. 104.

Moss, G. P., Gullick, D. R., Cox, P. A., Alexander, C., Ingram, M. J., Smart, J. D., & Pugh, W. J. 2006, "Design, synthesis and characterisation of captopril prodrugs for enhanced percutaneous absorption", J.Mater.Chem, vol. 58, pp. 167-177.

Moss, G. P. "Prodrugs for enhances percutaneous absorption - formulation and characterisation of drug-in-adhesive patch formulation", 10th Gordon Research Conference on Barrier Function of Mammalian Skin, Newport, RI.

Moss, G. P. 2007, "Cosmetic claims: getting under your skin", The Biochemist, vol. 29, pp. 8-10.

Moss, G. P., Sun, Y., Prapodopolou, M., Davey, N., & Brown, M. B. "Non-prametric Gaussian modelling of skin absorption using machine-learning methods", 9th Annual Meeting of Skin Forum, London, p. 56.

Moss, G. P., Sun, Y., Davey, N., Adams, R., Pugh, W. J., & Brown, M. B. 2009, "Pharmacology", J Pharmacy & Pharmacology, vol. 61, pp. 1147-1153.

Mucklow, J., Baber, N., Maxwell, S., & Pirmohamed, M. 2004, "The BPS web site for Continuing Professional Development in Clinical Pharmacology and Therapeutics", British Journal of Clinical Pharmacology, vol. 56, pp. 349-350.

Mynors, G. & Short, D. 2004, "New decision aid website launched for patients considering disease modifying drugs", Away Ahead, vol. 8, no. 3, pp. 5-6.

Nunes, V., Neilson, J., O'Flynn, N., Clyne, W., & et al 2009, Clinical Guidelines and Evidence Review for Medicines Adherence: Involving patients in decisions about prescribed medicines and supporting adherence. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners..

Palmer, I. A., Brown, M. B., Jones, S. A., Murnane, D., Moss, G. P., & Traynor, M. J. "The effect of amorphouis ad crystalline forms of clotrimazole for topical  drug delivery", Joint meeting: 10th annual meeting of Skin Forum, and 3rd APSI Skin & Formulation Symposium, Versailles, France, p. 81.

Palmer, I. A., Brown, M. B., Jones, S. A., Moss, G. P., & Traynor, M. J. "Novel powder formulation for toical delivery of micronazole nitrate and clotrimazole", 11th International Perspectives in Percutaneous Penetration, La Grande Mott, France, p. 72.

Panayiotis, P., Han, J., & Davis, S. Advances in the use of tocols as drug delivery vehicles. Pharmaceutical Research 23, 243-255. 2006.
Ref Type: Generic

Pantin, C., Mucklow, J., Rogers, D., Cross, M., & Wall, J. 2006, "Bedside Clinical Guidelines: the missing link.", Clin.Med, no. 6, pp. 98-104.

Pate, R., Fitzpatrick, R., & Woodvine, P. 2009, "Using prescribing activity comparators to change medicines use in secondary care", The Pharmaceutical Journal, vol. 283, pp. 597-598.

Pearson, R. J., Kassianidis, E., Slawin, A. M. Z., & Philps, D. 2004, "Self-replication vs. reactive binary complexes.  Manipulating recognition-mediated cycloadditions by simple structural modifications.", Org.Biomol.Chem., vol. 2, pp. 3434-3441.

Pearson, R. J., Kassianidis, E., & Philp, D. 2004, "A completely selective and strongly accelerated Diers-Alder reaction mediated by hydrogen bonding.", Tet.Lett., vol. 45, pp. 4777-4780.

Pearson, R. J., Slawin, A. M. Z., Philp, D., & Whorwell, P. 2005, "Controlling the outcome of an N-alkylation reaction using N-oxide functional groups.", Org.Chem., vol. 70, pp. 5055-5061.

Pearson, R. J., Kassianidis, E., Slawin, A. M. Z., & Philp, D. 2006, "Comparative analyses of a family of potential self-replicators: The subtle interplay between molecular structure and the efficacy of self-replicators.", Chem.Eur.J., vol. 12, no. 26, pp. 6829-6840.

Pearson, R. J. 2008, "1,2,3,5-dithiadiazoles and 1,3,2,4-dithiadiazoles.," in Comprehensive Heterocyclic Chemistry III, Elsevier, Oxford, pp. 499-515.

Perkins, M. C., Briggs, D., Rutten, F., Roberts, C. J., & Davies, M. C. 2007, "Cathionisation of oligometric alkylethoxylate surfactants to ToF-SIMS analysis.", Surface and Interface Analysis, vol. 39, pp. 644-647.

Perkins, M. C., Bell, G., Briggs, D., Davies, M. C., Friedman, A., Hart, C. A., Roberts, C. J., & Rutten, F. 2008, "The application of ToF-SIMS to the analysis of herbicide formulation penetration into and through leaf cuticles.", Colloids and Surfaces B: Biointerfaces, vol. 67, pp. 1-13.

Perumal, D. 2006, "Training to work in containment level 3.", Investigations: in University Teaching and Learning, vol. 4, no. 1.

Perumal, D. 2009, "Motivation theories and implications for teaching and learning in the Biosciences.", Investigations: in University Teaching and Learning, vol. 5, no. 2.

Phelan, M., Blenkinsopp, A., Hay, E., Foster, N., & Thomas, E. Effects of pharmacist-conducted medication review for chronic knee pain in Primary Care. Int J Pharm Pract 14 (Suppl 2), B54. 2006.
Ref Type: Generic

Pinna, R., Jamme, F., Rutten, F., Smith, E., Willis, M., Briggs, D., & McCoustra, M. Towards a fully optimised organic LED device: analysis of surface synthesis using coupling reactions by ToF-SIMS. Applied Surface Science , 6672. 2007.
Ref Type: Generic

Pollock, K. & Grime, J. 2003, "General practitioners' perspectives on managing time in consultations with patients suffering from depression: a qualitative study", Family Practice, vol. 20, pp. 262-269.

Pollock, K. & Grime, J. 2003, "The cost and cost-effectiveness of PPIs: GP perspectives and responses to a prescribing dilemma and their implications for the development of patient-centred healthcare", European Journal of General Practice, vol. 9, no. 4, pp. 126-140.

Pollock, K., Grime, J., Baker, E., & Mantala, K. 2004, "Meeting the information needs of psychiatric inpatients: staff and patient perspectives", Journal of Mental Health, vol. 13, no. 14, pp. 389-401.

Prapodopolou, M., Sun, Y., Adams, R., Davey, N., Brown, M. B., & Moss, G. P. "Prediction of skin penetration using machine learning methods", 11th International Perspectives in Percutaneoud Penetration, La Grande Mott, France, p. 59.

Price, D. & Duerden, M. 2003, "Chronic Obstructive Airways Disease", BMJ no. 326, pp. 1046-1047.

Pugh, W. J., Wong, R., Falson, F., Michniak, B. B., & Moss, G. P. 2005, "Discriminant analysis as a tool to identify compounds with potential as transdermal enhancers", J Pharmacy & Pharmacology, vol. 57, pp. 1389-1396.

Ranson, C., Fitzpatrick, R., Green, D., Allen, C., Seed, M., & Lewis, S. Validation of a Medicines Risk Assessment tool: a pilot study. IJPP 11[Supplement], R22. 2003.
Ref Type: Abstract

Ratcliffe, L. V., Rutten, F., Barrett, D. A., Whitmore, T., Seymour, D., Greenwood, C., Aranda-Gonzalvo, Y., Robinson, S., & McCoustra, M. 2007, "Rapid surface analysis under ambient conditions using plasma-assisted desorption ionization (PADI) mas spectrometry.", Analytical Chemistry, vol. 79, pp. 6094-6101.

Rawsterne, R. E., Gough, J., Rutten, F., Pham, N., Poon, W., Flitsch, S., Maltman, B., Alexander, M., & Ulijn, R. Controlling protein retention on enzyme-responsive surfaces. Surface and Interface Analysis 38, 1505. 2006.
Ref Type: Generic

Rawsterne, R. E., Gough, J. E., Farrar, D., Rutten, F., Alexander, M. R., Ulijn, R. V., & Todd, S. J. 2007, "Cell spreading correlates with LogP of amino acid surfaces.", Acta Biomaterialia, vol. 3, pp. 715-721.

Reid, M. L., Brown, M. B., Moss, G. P., & Jones, S. A. 2008, "An investigation into solvent-membrane interactions when assessing drug release from organic vehicles using regenerated cellulose membranes", J Pharmacy & Pharmacology, vol. 60, pp. 1139-1147.

Rutten, F., Briggs, D., Henderson, J., & Roe, M. J. 2009, "The application of time-of-flight secondary ion mass spectrometry.", Archaeometry, vol. 51, pp. 966-986.

Rutten, F., Henderson, J., & Briggs, D. Unlocking the secrets of ancient glass technology using ToF-SIMS. Spectroscopy Europe 17, 24. 2005.
Ref Type: Generic

Rutten, F., Roe, M., Henderson, J., & Briggs, D. Surface analysis of ancient glass artefacts with ToF-SIMS: a novel tool for provenacing? Applied Surface Science 252, 7124. 2006.
Ref Type: Generic

Rutten, F., Tadesse, H., & Licence, P. 2007, "Rewritable imaging on the surface of frozen ionic liquids.", Angewandte Chemie: International Edition, vol. 46, pp. 4163-4165.

Shali, S., Staff, K., & Moss, G. P. "Novel venlafaxine prodrugs for  enhances percutaneous absorption", Joint meeting: 10th Annual Meeting of Skin Forum, and 3rd APSI Skin & Formulation Symposium, p. 58.

Short, D., Frischer, M., & Bashford, J. 2003, "The development and evaluation of a computerised decision support system for primary care based upon 'patient profile decision analysis'.", Informatics in Primary Care, vol. 11 , pp. 195-202.

Short, D. & Norwood, J. 2003, "Why Is High-Tech Healthcare At Home Purchasing Underdeveloped And What Could Be Done To Improve It?", Health Services Management Research, vol. 16, pp. 127-135.

Short, D., Frischer, M., Bashford, J., & Ashcroft, D. 2003, "Why are eligible patients not prescribed aspirin in primary care?  A qualitative study indicating measures for improvement", BMC Fam Prac, vol. 4, p. 9.

Short, D., Frischer, M., & Bashford, J. 2004, "Barriers to the adoption of computerised decision support systems in general practice consultations: A qualitative study of GPs' perspectives", International Journal of Medical Informatics, vol. 73, pp. 357-362.

Short, D. & Frischer, M. Supporting the evidence based treatment of individual drug users: The case for 'patient profile decision analysis'. International Journal of Drug Policy . 2004.
Ref Type: In Press

Short, D., Stevens, C., & Crome, I. 2005, "UK addiction research 1994-2001: A profile of studies published in Addiction Abstracts", Drugs: Education, Prevention and Policy, vol. 12, no. 5, pp. 393-403.

Short, D., Stevens, C., & Crome, I. 2005, "A profile of studies published in Addiction Abstracts", Drugs: Education, Prevention and Policy, vol. 12, pp. 393-403.

Smith, G., Heatlie, H., Bashford, J., Hawker, J., Ashcroft, D., Millson, D., Verlander, N., & Warren, R. 2004, "What has happened to antimicrobial usage in primary care in the United Kingdom since the SMAC report? - Description of trends in antimicrobial usage using the General Practice Research Database", Journal of Public Health, vol. 26, pp. 359-364.

Smith, S., Smith, G., Heatlie, H., Bashford, J., Ashcroft, D., & Millson, D. 2003, "Head lice diagnosed in general practice in the West Midlands between 1993 and 2000: a survey using the General Practice Research Database", Communicable Disease and Public Health, vol. 6, no. 2, pp. 139-143.

Smith, S., Smith, G., Heatlie, H., Bashford, J., Ashcroft, D., Verlander, N., Duckworth, G., Mason, B., Smyth, B., & Maxwell, S. Reducing variation in antibacterial prescribing rates for 'cough/cold' and sore throat between 1993 and 2001 - regional analyses using the General Practice research Database. Public Health 120, 752-759. 2006.
Ref Type: Generic

Stebbings, J., Gazzard, B., Patterson, S., Bower, M., Perumal, D., Nelson, M., McMichael, A., Ogg, G., Epenetros, A., Gotch, F., & Savage, P. 2004, "Antibody targeted MHC complex directed expansion of HIV-1 and KSHV-specific CD8 positive lymphocytes: a new approach to therapeutic vaccination.", Blood, vol. 103, no. 5, pp. 1791-1795.

Sun, Y., Moss, G. P., Prapodopolou, M., Davey, N., Adams, R., & Brown, M. B. 2008, "Predictions of skin penetration using machine learning methods," in Proceedings of 8th IEEE International Conference on Data Mining (ICDM 2008), Giannotti.F et al., eds., Pisa, Italy.

Sun, Y., Brown, M. B., Prapodopolou, M., Adams, R., Davey, N., & Moss, G. P. "The application of Gaussian Processes in the prediction of absorption across mammalian sin and synthetic membranes", 12th International perspectives in percutaneous penetration.

Thrower, J., Collings, M., Rutten, F., & McCoustra, M. 2009, "Thermal desorption of C6H6 from surfaces of astrophysical relevance", Journal of Chemical Physics, vol. 131, pp. 244711-244720.

Thrower, J., Connock, M. J., Savage, P., Rutten, F., & McKeever, T. 2009, "Laboratory investigations of the interaction between benzene and bare silicate grain surfaces.", Mon.Not.R.Astron.Soc., vol. 394, p. 1510.

Tober, G., Clyne, W., Finnegan, O., Farrin, A., & Russell, I. Validation of a scale for rating the delivery of psycho-social treatment for alcohol dependence and misuse: The UKATT process rating scale (PRS). Alcohol & Alcoholism.  2008.
Ref Type: Generic

Tobin, M., Chesters, M., Chalmers, J., Fisher, S., Rutten, F., Symonds, I., Hitchcock, A., MacLennan, K., Allibone, R., & Dias-gunasekara, S. Infrared microspectroscopy in cancer diagnosis. British Journal of Cancer 91, S44-S44 Supple. 1. 2004.
Ref Type: Generic

Tobin, M., Chesters, M., Chalmers, J., Rutten, F., Fisher, S., Symonds, I., Hitchcock, A., Allibone, R., & Dias-gunasekara, S. Infrared microscopy of epithelial cancer cells in whole tissues and in tissue culture, using synchrotron radiation. Faraday Discussions 126, 27. 2004.
Ref Type: Generic

Tsouraspas, G., Rutten, F., Briggs, D., Davies, M., & Shakesheff, K. Surface spectroscopic imaging of PEG-PLA tissue engineering constructs with ToF-SIMS. Applied Surface Science 252, 6693. 2006.
Ref Type: Generic

Tuleu, C., Han, J., Bingen, C., Hardyal, G., Shah, J., & Cope, J. 'In use' stability testing of paediatric CIV AS pre-filled syringes of morphine sulphate in glucose.  2005.  Neonatal and Paediatric Pharmacists Group Conference.
Ref Type: Generic

Villar Garcia, I., Rutten, F., Smith, E., Briggs, D., & Licence, P. Ionic liquids in-vacuo: the analysis of liquid surfaces using UHV techniques. Langmuir 22, 9386. 2006.
Ref Type: Generic

Wan, K.-W., Malgesini, B., Verpilio, I., Ferruti, P., Griffiths, P., & Duncan, R. Poly(amidoamine) salt form: effect on pH-dependent membrane activity and polymer conformation in solution. Biomacromolecules 5, 1102-1109. 2004.
Ref Type: Generic

Westbury, J., Pollock, K., & Blenkinsopp, A. A study of concordance issues for older people. IJPP 11[Supplement]. 2003.
Ref Type: Abstract

Woodvine, P., Pate, R., & Chapman, S. Using IMS hospital drug issue date to enable secondary care prescribers to assist primary care trusts with their objectives and targets. (Abstract). Pharmacoepidemiology and Drug Safety 16, 588-595. 2007.
Ref Type: Generic

Xiaohui, P., Sun, J., Wang, Y., Wang, Y., Liu, X., Zhang, P., Tang, X., Pan, W., Han, J., & He, Z. 2009, "Development of a chemically stable 10-hydroxycamptothecin nanosuspension using microprecipotation-high pressure homogenization", International Journal of Pharmaceutics, vol. 379, pp. 167-173.

Top 10 CUG Top 5 Guardian Athena SWAN